Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
A comprehensive integrated molecular map of sarcomas
EF 2019-20
Résumé
"Sarcomas are a rare group of aggressive soft tissue and bone cancers that disproportionally affect pediatric patients. Currently, many are difficult to diagnose, and most are treated with traditional anti-cancer therapies. Unfortunately, potential advances are hampered by a poor understanding of the underlying genetic processes in sarcomas, which would otherwise reveal diagnostic and/or treatable molecular features.Recent advances in machine learning and sequencing technologies have revealed new opportunities to discover and catalogue the specific genomic events which push otherwise healthy cells to develop into cancers. Using over 12 000 samples of many cancer types, our lab has created a machine learning algorithm which generates a map based on each cancer types unique pattern of DNA usage, including sarcomas. This map successfully classifies blood and brain cancers and has been used at the Hospital for Sick Children in Toronto as part of the Kids Cancer Sequencing (KiCS) program.We now propose to use this unparalleled tool to classify all sarcoma types on a molecular level. Using next-generation sequencing technology, we will investigate the genetic and related processes driving the development of each sarcoma type, emphasizing subtype-specific markers and the identification of treatable features. We will then incorporate these findings into a comprehensive map made up of new, more clinically relevant sarcoma subtypes.We hope this research will ultimately streamline diagnosis and the selection of effective and targeted treatment options for pediatric and adult sarcoma patients. Our ultimate goal is to provide a platform to direct further enquiries into sarcoma development, and to encourage clinical improvements to mortality rate and patient quality of life."
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
429015
Name
Nash Joshua O
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
A comprehensive integrated molecular map of sarcomas
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Cell-Of-Origin; Chromatin Landscapes; Hierarchical Clustering; Machine Learning; Mutational Signatures; Next-Generation Sequencing; Oncogenesis; Sarcoma; Transcription
Abstract
"Sarcomas are a rare group of aggressive soft tissue and bone cancers that disproportionally affect pediatric patients. Currently, many are difficult to diagnose, and most are treated with traditional anti-cancer therapies. Unfortunately, potential advances are hampered by a poor understanding of the underlying genetic processes in sarcomas, which would otherwise reveal diagnostic and/or treatable molecular features.Recent advances in machine learning and sequencing technologies have revealed new opportunities to discover and catalogue the specific genomic events which push otherwise healthy cells to develop into cancers. Using over 12 000 samples of many cancer types, our lab has created a machine learning algorithm which generates a map based on each cancer types unique pattern of DNA usage, including sarcomas. This map successfully classifies blood and brain cancers and has been used at the Hospital for Sick Children in Toronto as part of the Kids Cancer Sequencing (KiCS) program.We now propose to use this unparalleled tool to classify all sarcoma types on a molecular level. Using next-generation sequencing technology, we will investigate the genetic and related processes driving the development of each sarcoma type, emphasizing subtype-specific markers and the identification of treatable features. We will then incorporate these findings into a comprehensive map made up of new, more clinically relevant sarcoma subtypes.We hope this research will ultimately streamline diagnosis and the selection of effective and targeted treatment options for pediatric and adult sarcoma patients. Our ultimate goal is to provide a platform to direct further enquiries into sarcoma development, and to encourage clinical improvements to mortality rate and patient quality of life."
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Nash, Joshua O
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~